Sunday, July 05, 2020 11:08:20 PM
Well , I will not be happy with 10-15 , with all those diseases this will be a big disappointment to me ..
I must say that with time medicine not appreciation in price here became my priority , but still I am an investor , and I am here close to 5 years , mostly being down for those years with lots of money invested , about 60-70% down until mid of December 2019 ...
As everything else was going up in the market I was going down , but reading about results with our drug , I never gave up.......
I read some posters here now , with nice posts , but I remember their terrible posts 1-2-3 years ago , cursing Dr NP and everyone who was positive here ,
I was the first one attacked , it is a joke when I read their posts now..
Yes it was not very easy...
I stayed for science...I am a very big believer...
And I know that when shareholders like myself and many others , losing for years really LOTs of money ... taking big chances that things may never be better...
When things looks great in HIV, cancer , covid , NASH , MS , Altzheimer and many other ,
10-15 doll is imo not serious price to talk about..
And Personally I love Dr NP to give company predictions...His PRs and prediction I love it...
But we all different.. my best luck to you , whatever you be happy with...if 15 will be it , my prediction is , you be selling within few months ...:))
And that is fine , others I am sure will buy your shares...
My best...
All IMO..
I must say that with time medicine not appreciation in price here became my priority , but still I am an investor , and I am here close to 5 years , mostly being down for those years with lots of money invested , about 60-70% down until mid of December 2019 ...
As everything else was going up in the market I was going down , but reading about results with our drug , I never gave up.......
I read some posters here now , with nice posts , but I remember their terrible posts 1-2-3 years ago , cursing Dr NP and everyone who was positive here ,
I was the first one attacked , it is a joke when I read their posts now..
Yes it was not very easy...
I stayed for science...I am a very big believer...
And I know that when shareholders like myself and many others , losing for years really LOTs of money ... taking big chances that things may never be better...
When things looks great in HIV, cancer , covid , NASH , MS , Altzheimer and many other ,
10-15 doll is imo not serious price to talk about..
And Personally I love Dr NP to give company predictions...His PRs and prediction I love it...
But we all different.. my best luck to you , whatever you be happy with...if 15 will be it , my prediction is , you be selling within few months ...:))
And that is fine , others I am sure will buy your shares...
My best...
All IMO..
Recent CYDY News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:35:02 PM
- CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
- CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference • GlobeNewswire Inc. • 02/20/2026 01:30:00 PM
- CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer • GlobeNewswire Inc. • 01/27/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/09/2026 10:15:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/09/2026 01:30:45 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/22/2025 10:15:23 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/17/2025 05:15:14 AM
- December 2025 Letter to Shareholders • GlobeNewswire Inc. • 12/16/2025 01:30:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 12/10/2025 10:16:32 PM
- CytoDyn to Showcase PD-L1 Upregulation and Improved Survival in Metastatic Triple Negative Breast Cancer at the San Antonio Breast Cancer Symposium • GlobeNewswire Inc. • 12/08/2025 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/02/2025 10:15:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 01:40:20 PM
- CytoDyn Announces Resolution of Class Action Lawsuit • GlobeNewswire Inc. • 12/01/2025 01:30:00 PM
